INVO Bioscience Announces Pricing of Follow-on Public Offering and Listing on the NASDAQ Capital Market
SARASOTA, Fla., Nov. 12, 2020 /PRNewswire/ — INVO Bioscience, Inc. (OTCQB: INVOD) (Nasdaq: INVO) developers of INVOcell®, the world’s...
Author: investleafwebservices@gmail.com
Health Assurance Acquisition Corp. Announces Pricing of $500 Million Initial Public Offering
SAN FRANCISCO, Nov. 12, 2020 (GLOBE NEWSWIRE) — Health Assurance Acquisition Corp. (the “Company”) announced today that it priced...
Intermap Technologies Completes Private Placement
Closes additional tranches raising $2.0 million at $1.03 per shareTotal gross proceeds exceed $3.75 millionMore than $5.5 million raised...
Hydrofarm Holdings Group Files Registration Statement for Proposed Initial Public Offering
PETALUMA, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — Hydrofarm Holdings Group, Inc. (“Hydrofarm”), a leading independent branded hydroponics company...
CF Finance Acquisition Corp. III Announces Pricing of $200 Million Initial Public Offering
New York, New York, Nov. 12, 2020 (GLOBE NEWSWIRE) — CF Finance Acquisition Corp. III (Nasdaq: CFACU, the “Company”)...
Cullen/Frost Announces Pricing Of $150 Million Depositary Shares Offering
SAN ANTONIO, Nov. 12, 2020 /PRNewswire/ — Cullen/Frost Bankers, Inc. (NYSE: CFR) (“Cullen/Frost”) today announced the pricing of a...
Chemours Announces Pricing Of Private Offering Of $800 Million Aggregate Principal Amount Of 5.750% Senior Unsecured Notes Due 2028
WILMINGTON, Del., Nov. 12, 2020 /PRNewswire/ — The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market...
Cassava Sciences Announces Proposed Public Offering of Common Stock
AUSTIN, Texas, Nov. 12, 2020 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company” or “Cassava Sciences”), a...
InMed Announces Pricing of US$8M Public Offering and Listing on the Nasdaq Capital Market Under the Symbol “INM”
VANCOUVER, BC, Nov. 12, 2020 /PRNewswire/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ: INM) (TSX: IN), a clinical-stage...
Chemours Announces Proposed Private Offering of $750 Million Aggregate Principal Amount of Senior Unsecured Notes
WILMINGTON, Del., Nov. 12, 2020 /PRNewswire/ — The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market...